HK2 and ovarian carcinoma: Moreover, we show that IL-6, but not IL-8, is one of the major cytokines in CAF-CM that contributes to HK2 up-regulation through binding of IL-6R in ovarian cancer cells, suggesting that HK2 expression can be regulated by the tumor microenvironment in ovarian cancer.